Theravance, Inc. (THRX) Tops Q2 EPS by 2c
Tweet Send to a FriendGet Alerts THRX Hot Sheet
Price: $35.58 -0.36%
Revenue Growth %: -99.0%
Financial Fact:
Loss from operations: -33.39M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -99.0%
Financial Fact:
Loss from operations: -33.39M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade THRX Now!
Theravance, Inc. (NASDAQ: THRX) reported Q2 EPS of ($0.42), $0.02 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $1.97 million.
For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Elan Shareholders Do Not Approve Theravance/Elan Royalty Participation Transaction
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
- Motorcar Parts of America, Inc. (MPAA) Widens Q4 Loss to 14c/Share
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
